These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15493113)

  • 81. Uric acid and cardiovascular risk.
    Feig DI; Kang DH; Johnson RJ
    N Engl J Med; 2008 Oct; 359(17):1811-21. PubMed ID: 18946066
    [No Abstract]   [Full Text] [Related]  

  • 82. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
    Kang DH; Nakagawa T
    Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Hyperuricemia and cardiovascular diseases: from phylogenesys to patogenetic mechanisms].
    Trepiccione F; Perna AF
    G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005870
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The role of uric acid in the development of cardiovascular disease.
    Borghi C
    Curr Med Res Opin; 2015; 31 Suppl 2():1-2. PubMed ID: 26414729
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study.
    Desideri G; Virdis A; Casiglia E; Borghi C;
    High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):197-202. PubMed ID: 29427170
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Hyperuricemia and uro-nephrological disorders].
    Hurtes X; Meria P
    Presse Med; 2011 Sep; 40(9 Pt 1):865-8. PubMed ID: 21684106
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Uric acid as a cardiorenal mediator: pathogenesis and mechanistic insights.
    Gulab A; Torres R; Pelayo J; Lo KB; Shahzad A; Pradhan S; Rangaswami J
    Expert Rev Cardiovasc Ther; 2021 Jun; 19(6):547-556. PubMed ID: 34112023
    [No Abstract]   [Full Text] [Related]  

  • 88. Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans?
    Longo-Mbenza B; Luila EL; Mbete P; Vita EK
    Int J Cardiol; 1999 Sep; 71(1):17-22. PubMed ID: 10522560
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Uric acid 8.4 in an asymptomatic patient. Does he need medication?].
    Füessl HS
    MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():22. PubMed ID: 22916420
    [No Abstract]   [Full Text] [Related]  

  • 90. Uric acid: a novel mediator and marker of risk in chronic kidney disease?
    Feig DI
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):526-30. PubMed ID: 19654543
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Part 1. Uric acid and losartan.
    Sica DA; Schoolwerth AC
    Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):475-82. PubMed ID: 12187310
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review.
    Vinik O; Wechalekar MD; Falzon L; Buchbinder R; van der Heijde DM; Bombardier C
    J Rheumatol Suppl; 2014 Sep; 92():70-4. PubMed ID: 25180131
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?
    Dawson J; Walters M
    Br J Clin Pharmacol; 2006 Dec; 62(6):633-44. PubMed ID: 21894646
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Update in uric acid, hypertension, and cardiovascular diseases.
    Kuwabara M; Kodama T; Ae R; Kanbay M; Andres-Hernando A; Borghi C; Hisatome I; Lanaspa MA
    Hypertens Res; 2023 Jul; 46(7):1714-1726. PubMed ID: 37072573
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Endothelial function in patients with arterial hypertension and impaired uric acid metabolism].
    Lebedeva MV; Stakhova TIu; Minakova EG; Zaĭtseva LI; Severova MM; Pulin AA
    Vestn Ross Akad Med Nauk; 2010; (12):44-6. PubMed ID: 21395065
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism.
    Takahashi S; Moriwaki Y; Yamamoto T; Tsutsumi Z; Ka T; Fukuchi M
    Ann Rheum Dis; 2003 Jun; 62(6):572-5. PubMed ID: 12759298
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects.
    Cortese F; Giordano P; Scicchitano P; Faienza MF; De Pergola G; Calculli G; Meliota G; Ciccone MM
    Vascul Pharmacol; 2019 Sep; 120():106565. PubMed ID: 31152976
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Hyperuricemia and Atrial Fibrillation.
    Maharani N; Kuwabara M; Hisatome I
    Int Heart J; 2016 Jul; 57(4):395-9. PubMed ID: 27396561
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Elevated uric acid and cardiovascular disease. How strong is the evidence of a pathogenetic link?
    Toschi V
    Intern Emerg Med; 2007 Dec; 2(4):320-1. PubMed ID: 18172598
    [No Abstract]   [Full Text] [Related]  

  • 100. Treatment of hyperuricemia in essential hypertension.
    Trachtman H
    Hypertension; 2007 Jun; 49(6):e45; author reply e46. PubMed ID: 17389252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.